Search Results - F. Smit

Refine Results
  1. 1

    Holiday effects in the South African futures market by C. F. Smit, E. V.D.M. Smit

    Get full text
    Article


  2. 2

    BRAFV600E-mutant metastatic NSCLC: disease overview and treatment landscape by David Planchard, Rachel E. Sanborn, Marcelo V. Negrao, Aria Vaishnavi, Egbert F. Smit

    Published in npj Precision Oncology (2024-04-01)
    Get full text
    Article


  3. 3

    Author Correction: BRAFV600E-mutant metastatic NSCLC: disease overview and treatment landscape by David Planchard, Rachel E. Sanborn, Marcelo V. Negrao, Aria Vaishnavi, Egbert F. Smit

    Published in npj Precision Oncology (2024-07-01)
    Get full text
    Article


  4. 4

    Bilateral squamous cell carcinoma of the temporal bone: A report of two cases and a systematic review of the literature by N. Hoogenes, M. Tomasoni, P. Merkus, B.I. Lissenberg-Witte, C.R. Leemans, A. Deganello, C.F. Smit

    Published in Journal of Otology (2024-10-01)
    Get full text
    Article


  5. 5

    Surgical treatment for squamous cell carcinoma of the temporal bone: predictors of survival by Conrad F. Smit, Niels de Boer, Birgit I. Lissenberg-Witte, Paul Merkus, Erik F. Hensen, C. René Leemans

    Published in Acta Otorhinolaryngologica Italica (2021-08-01)
    Get full text
    Article


  6. 6

    Early response evaluation of PD-1 blockade in NSCLC patients through FDG-PET-CT and T cell profiling of tumor-draining lymph nodes by Frank J. Borm, Jasper Smit, Joyce Bakker, Maurits Wondergem, Egbert F. Smit, Adrianus J. de Langen, Tanja D. de Gruijl

    Published in OncoImmunology (2023-12-01)
    Get full text
    Article


  7. 7

    Pembrolizumab hybrid dosing is non-inferior to flat dosing in advanced non-small cell lung cancer: a real-world, retrospective bicenter cohort study by Egbert F Smit, Willemijn S M E Theelen, Michiel M Smeenk, Vincent van der Noort, Jeroen M A Hendrikx, Hanieh Abedian Kalkhoran

    Published in Journal for ImmunoTherapy of Cancer (2025-02-01)
    Get full text
    Article


  8. 8

    Response to: Correspondence on ‘Pembrolizumab hybrid dosing is non-inferior to flat dosing in advanced non-small cell lung cancer-a real-world, retrospective bicenter cohort study’... by Egbert F Smit, Willemijn S M E Theelen, Michiel M Smeenk, Vincent van der Noort, Hanieh Abedian Kalkhoran, Jeroen J M A Hendrikx

    Published in Journal for ImmunoTherapy of Cancer (2025-07-01)
    Get full text
    Article


  9. 9

    Response to: Comment on ’Pembrolizumab hybrid dosing is non-inferior to flat dosing in advanced non-small cell lung cancer: a real-world, retrospective bicenter cohort study’ by Zh... by Egbert F Smit, Willemijn S M E Theelen, Michiel M Smeenk, Vincent van der Noort, Hanieh Abedian Kalkhoran, Jeroen J M A Hendrikx

    Published in Journal for ImmunoTherapy of Cancer (2025-07-01)
    Get full text
    Article


  10. 10

    Head-to-head comparison of composite and individual biomarkers to predict clinical benefit to PD-1 blockade in non-small cell lung cancer. by Karlijn Hummelink, Vincent van der Noort, Mirte Muller, Robert D Schouten, Michel M van den Heuvel, Daniela S Thommen, Egbert F Smit, Gerrit A Meijer, Kim Monkhorst

    Published in PLoS ONE (2024-01-01)
    Get full text
    Article


  11. 11

    A text-mining approach to study the real-world effectiveness and potentially fatal immune-related adverse events of PD-1 and PD-L1 inhibitors in older patients with stage III/IV no... by Hanieh Abedian Kalkhoran, Juliëtte Zwaveling, Bert N. Storm, Sylvia A. van Laar, Johanneke EA Portielje, Henk Codrington, Dieuwke Luijten, Pepijn Brocken, Egbert F. Smit, Loes E. Visser

    Published in BMC Cancer (2023-03-01)
    Get full text
    Article


  12. 12

    Tumour growth rate as a tool for response evaluation during PD-1 treatment for non-small cell lung cancer: a retrospective analysis by Deirdre M.H.J. ten Berge, Daniel P. Hurkmans, Ilse den Besten, Jeroen S. Kloover, Ron H.J. Mathijssen, Reno Debets, Egbert F. Smit, Joachim G.J.V. Aerts

    Published in ERJ Open Research (2019-12-01)
    Get full text
    Article


  13. 13

    A Fast, Sensitive and Accurate High Resolution Melting (HRM) Technology-Based Assay to Screen for Common K-ras Mutations by D. Kramer, F. B. Thunnissen, M. I. Gallegos-Ruiz, E. F. Smit, P. E. Postmus, C. J. L. M. Meijer, P.J.F. Snijders, D. A. M. Heideman

    Published in Cellular Oncology (2009-01-01)
    Get full text
    Article


  14. 14

    Challenges in Establishing Pure Lung Cancer Organoids Limit Their Utility for Personalized Medicine by Krijn K. Dijkstra, Kim Monkhorst, Luuk J. Schipper, Koen J. Hartemink, Egbert F. Smit, Sovann Kaing, Rosa de Groot, Monika C. Wolkers, Hans Clevers, Edwin Cuppen, Emile E. Voest

    Published in Cell Reports (2020-05-01)
    Get full text
    Article


  15. 15

    Correction: Clonality analysis of pulmonary tumors by genome-wide copy number profiling. by Julien P L Vincenten, Hendrik F van Essen, Birgit I Lissenberg-Witte, Nicole W J Bulkmans, Oscar Krijgsman, Daoud Sie, Paul P Eijk, Egbert F Smit, Bauke Ylstra, Erik Thunnissen

    Published in PLoS ONE (2019-01-01)
    Get full text
    Article


  16. 16

    Clonality analysis of pulmonary tumors by genome-wide copy number profiling. by Julien P L Vincenten, Hendrik F van Essen, Birgit I Lissenberg-Witte, Nicole W J Bulkmans, Oscar Krijgsman, Daoud Sie, Paul P Eijk, Egbert F Smit, Bauke Ylstra, Erik Thunnissen

    Published in PLoS ONE (2019-01-01)
    Get full text
    Article


  17. 17

    A Panel of High Resolution Melting (HRM) Technology-Based Assays with Direct Sequencing Possibility for Effective Mutation Screening of EGFR and K-ras Genes by D. A. M. Heideman, F. B. Thunnissen, M. Doeleman, D. Kramer, H. M. Verheul, E. F. Smit, P. E. Postmus, C. J. L. M. Meijer, G.A. Meijer, P. J. F. Snijders

    Published in Cellular Oncology (2009-01-01)
    Get full text
    Article


  18. 18

    Identification of protein biomarkers for prediction of response to platinum‐based treatment regimens in patients with non‐small cell lung cancer by Franziska Böttger, Teodora Radonic, Idris Bahce, Kim Monkhorst, Sander R. Piersma, Thang V. Pham, Anne‐Marie C. Dingemans, Lisa M. Hillen, Mariacarmela Santarpia, Elisa Giovannetti, Egbert F. Smit, Sjaak A. Burgers, Connie R. Jimenez

    Published in Molecular Oncology (2024-06-01)
    Get full text
    Article


  19. 19

    Integrated noninvasive diagnostics for prediction of survival in immunotherapy by M. Yeghaian, Z. Bodalal, T.M. Tareco Bucho, I. Kurilova, C.U. Blank, E.F. Smit, M.S. van der Heijden, T.D.L. Nguyen-Kim, D. van den Broek, R.G.H. Beets-Tan, S. Trebeschi

    Published in Immuno-Oncology and Technology (2024-12-01)
    Get full text
    Article


  20. 20

    Analysis of AKT and ERK1/2 protein kinases in extracellular vesicles isolated from blood of patients with cancer by Johannes C. van der Mijn, Nik Sol, Wouter Mellema, Connie R. Jimenez, Sander R. Piersma, Henk Dekker, Lisette M. Schutte, Egbert F. Smit, Henk J. Broxterman, Johan Skog, Bakhos A. Tannous, Thomas Wurdinger, Henk M. W. Verheul

    Published in Journal of Extracellular Vesicles (2014-12-01)
    Get full text
    Article


Search Tools: